Global Diagnostic Nuclear Drug Market Growth (Status and Outlook) 2022-2028
- LP 4894290
- 102 Pages
- March 2022
- Pharmaceuticals
The United States Diagnostic Nuclear Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Diagnostic Nuclear Drug market, reaching US$ million by the year 2028. As for the Europe Diagnostic Nuclear Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Diagnostic Nuclear Drug players cover Bracco Imaging, Bayer, Curium Pharmaceuticals, and Nordion, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Nuclear Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Tc-99m
F-18
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Oncology
Cardiology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bracco Imaging
Bayer
Curium Pharmaceuticals
Nordion
Triad Isotopes
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
SIEMENS
Dongcheng
Navidea
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diagnostic Nuclear Drug Market Size 2017-2028
2.1.2 Diagnostic Nuclear Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Diagnostic Nuclear Drug Segment by Type
2.2.1 Tc-99m
2.2.2 F-18
2.2.3 Other
2.3 Diagnostic Nuclear Drug Market Size by Type
2.3.1 Diagnostic Nuclear Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Diagnostic Nuclear Drug Market Size Market Share by Type (2017-2022)
2.4 Diagnostic Nuclear Drug Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Diagnostic Nuclear Drug Market Size by Application
2.5.1 Diagnostic Nuclear Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Diagnostic Nuclear Drug Market Size Market Share by Application (2017-2022)
3 Diagnostic Nuclear Drug Market Size by Player
3.1 Diagnostic Nuclear Drug Market Size Market Share by Players
3.1.1 Global Diagnostic Nuclear Drug Revenue by Players (2020-2022)
3.1.2 Global Diagnostic Nuclear Drug Revenue Market Share by Players (2020-2022)
3.2 Global Diagnostic Nuclear Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Diagnostic Nuclear Drug by Regions
4.1 Diagnostic Nuclear Drug Market Size by Regions (2017-2022)
4.2 Americas Diagnostic Nuclear Drug Market Size Growth (2017-2022)
4.3 APAC Diagnostic Nuclear Drug Market Size Growth (2017-2022)
4.4 Europe Diagnostic Nuclear Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Diagnostic Nuclear Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Diagnostic Nuclear Drug Market Size by Country (2017-2022)
5.2 Americas Diagnostic Nuclear Drug Market Size by Type (2017-2022)
5.3 Americas Diagnostic Nuclear Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diagnostic Nuclear Drug Market Size by Region (2017-2022)
6.2 APAC Diagnostic Nuclear Drug Market Size by Type (2017-2022)
6.3 APAC Diagnostic Nuclear Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Diagnostic Nuclear Drug by Country (2017-2022)
7.2 Europe Diagnostic Nuclear Drug Market Size by Type (2017-2022)
7.3 Europe Diagnostic Nuclear Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Diagnostic Nuclear Drug by Region (2017-2022)
8.2 Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Diagnostic Nuclear Drug Market Forecast
10.1 Global Diagnostic Nuclear Drug Forecast by Regions (2023-2028)
10.1.1 Global Diagnostic Nuclear Drug Forecast by Regions (2023-2028)
10.1.2 Americas Diagnostic Nuclear Drug Forecast
10.1.3 APAC Diagnostic Nuclear Drug Forecast
10.1.4 Europe Diagnostic Nuclear Drug Forecast
10.1.5 Middle East & Africa Diagnostic Nuclear Drug Forecast
10.2 Americas Diagnostic Nuclear Drug Forecast by Country (2023-2028)
10.2.1 United States Diagnostic Nuclear Drug Market Forecast
10.2.2 Canada Diagnostic Nuclear Drug Market Forecast
10.2.3 Mexico Diagnostic Nuclear Drug Market Forecast
10.2.4 Brazil Diagnostic Nuclear Drug Market Forecast
10.3 APAC Diagnostic Nuclear Drug Forecast by Region (2023-2028)
10.3.1 China Diagnostic Nuclear Drug Market Forecast
10.3.2 Japan Diagnostic Nuclear Drug Market Forecast
10.3.3 Korea Diagnostic Nuclear Drug Market Forecast
10.3.4 Southeast Asia Diagnostic Nuclear Drug Market Forecast
10.3.5 India Diagnostic Nuclear Drug Market Forecast
10.3.6 Australia Diagnostic Nuclear Drug Market Forecast
10.4 Europe Diagnostic Nuclear Drug Forecast by Country (2023-2028)
10.4.1 Germany Diagnostic Nuclear Drug Market Forecast
10.4.2 France Diagnostic Nuclear Drug Market Forecast
10.4.3 UK Diagnostic Nuclear Drug Market Forecast
10.4.4 Italy Diagnostic Nuclear Drug Market Forecast
10.4.5 Russia Diagnostic Nuclear Drug Market Forecast
10.5 Middle East & Africa Diagnostic Nuclear Drug Forecast by Region (2023-2028)
10.5.1 Egypt Diagnostic Nuclear Drug Market Forecast
10.5.2 South Africa Diagnostic Nuclear Drug Market Forecast
10.5.3 Israel Diagnostic Nuclear Drug Market Forecast
10.5.4 Turkey Diagnostic Nuclear Drug Market Forecast
10.5.5 GCC Countries Diagnostic Nuclear Drug Market Forecast
10.6 Global Diagnostic Nuclear Drug Forecast by Type (2023-2028)
10.7 Global Diagnostic Nuclear Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Bracco Imaging
11.1.1 Bracco Imaging Company Information
11.1.2 Bracco Imaging Diagnostic Nuclear Drug Product Offered
11.1.3 Bracco Imaging Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bracco Imaging Main Business Overview
11.1.5 Bracco Imaging Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Diagnostic Nuclear Drug Product Offered
11.2.3 Bayer Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 Curium Pharmaceuticals
11.3.1 Curium Pharmaceuticals Company Information
11.3.2 Curium Pharmaceuticals Diagnostic Nuclear Drug Product Offered
11.3.3 Curium Pharmaceuticals Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Curium Pharmaceuticals Main Business Overview
11.3.5 Curium Pharmaceuticals Latest Developments
11.4 Nordion
11.4.1 Nordion Company Information
11.4.2 Nordion Diagnostic Nuclear Drug Product Offered
11.4.3 Nordion Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Nordion Main Business Overview
11.4.5 Nordion Latest Developments
11.5 Triad Isotopes
11.5.1 Triad Isotopes Company Information
11.5.2 Triad Isotopes Diagnostic Nuclear Drug Product Offered
11.5.3 Triad Isotopes Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Triad Isotopes Main Business Overview
11.5.5 Triad Isotopes Latest Developments
11.6 Lantheus
11.6.1 Lantheus Company Information
11.6.2 Lantheus Diagnostic Nuclear Drug Product Offered
11.6.3 Lantheus Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Lantheus Main Business Overview
11.6.5 Lantheus Latest Developments
11.7 GE Healthcare
11.7.1 GE Healthcare Company Information
11.7.2 GE Healthcare Diagnostic Nuclear Drug Product Offered
11.7.3 GE Healthcare Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 GE Healthcare Main Business Overview
11.7.5 GE Healthcare Latest Developments
11.8 China Isotope & Radiation
11.8.1 China Isotope & Radiation Company Information
11.8.2 China Isotope & Radiation Diagnostic Nuclear Drug Product Offered
11.8.3 China Isotope & Radiation Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 China Isotope & Radiation Main Business Overview
11.8.5 China Isotope & Radiation Latest Developments
11.9 Jubilant Pharma
11.9.1 Jubilant Pharma Company Information
11.9.2 Jubilant Pharma Diagnostic Nuclear Drug Product Offered
11.9.3 Jubilant Pharma Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Jubilant Pharma Main Business Overview
11.9.5 Jubilant Pharma Latest Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Information
11.10.2 Eli Lilly Diagnostic Nuclear Drug Product Offered
11.10.3 Eli Lilly Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Eli Lilly Main Business Overview
11.10.5 Eli Lilly Latest Developments
11.11 Novartis
11.11.1 Novartis Company Information
11.11.2 Novartis Diagnostic Nuclear Drug Product Offered
11.11.3 Novartis Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Novartis Main Business Overview
11.11.5 Novartis Latest Developments
11.12 SIEMENS
11.12.1 SIEMENS Company Information
11.12.2 SIEMENS Diagnostic Nuclear Drug Product Offered
11.12.3 SIEMENS Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 SIEMENS Main Business Overview
11.12.5 SIEMENS Latest Developments
11.13 Dongcheng
11.13.1 Dongcheng Company Information
11.13.2 Dongcheng Diagnostic Nuclear Drug Product Offered
11.13.3 Dongcheng Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Dongcheng Main Business Overview
11.13.5 Dongcheng Latest Developments
11.14 Navidea
11.14.1 Navidea Company Information
11.14.2 Navidea Diagnostic Nuclear Drug Product Offered
11.14.3 Navidea Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Navidea Main Business Overview
11.14.5 Navidea Latest Developments
12 Research Findings and Conclusion
Table 1. Diagnostic Nuclear Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Tc-99m
Table 3. Major Players of F-18
Table 4. Major Players of Other
Table 5. Diagnostic Nuclear Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Diagnostic Nuclear Drug Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Diagnostic Nuclear Drug Market Size Market Share by Type (2017-2022)
Table 8. Diagnostic Nuclear Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Diagnostic Nuclear Drug Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Diagnostic Nuclear Drug Market Size Market Share by Application (2017-2022)
Table 11. Global Diagnostic Nuclear Drug Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Diagnostic Nuclear Drug Revenue Market Share by Player (2020-2022)
Table 13. Diagnostic Nuclear Drug Key Players Head office and Products Offered
Table 14. Diagnostic Nuclear Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Diagnostic Nuclear Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Diagnostic Nuclear Drug Market Size Market Share by Regions (2017-2022)
Table 19. Americas Diagnostic Nuclear Drug Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Diagnostic Nuclear Drug Market Size Market Share by Country (2017-2022)
Table 21. Americas Diagnostic Nuclear Drug Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Diagnostic Nuclear Drug Market Size Market Share by Type (2017-2022)
Table 23. Americas Diagnostic Nuclear Drug Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Diagnostic Nuclear Drug Market Size Market Share by Application (2017-2022)
Table 25. APAC Diagnostic Nuclear Drug Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Diagnostic Nuclear Drug Market Size Market Share by Region (2017-2022)
Table 27. APAC Diagnostic Nuclear Drug Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Diagnostic Nuclear Drug Market Size Market Share by Type (2017-2022)
Table 29. APAC Diagnostic Nuclear Drug Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Diagnostic Nuclear Drug Market Size Market Share by Application (2017-2022)
Table 31. Europe Diagnostic Nuclear Drug Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Diagnostic Nuclear Drug Market Size Market Share by Country (2017-2022)
Table 33. Europe Diagnostic Nuclear Drug Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Diagnostic Nuclear Drug Market Size Market Share by Type (2017-2022)
Table 35. Europe Diagnostic Nuclear Drug Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Diagnostic Nuclear Drug Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Diagnostic Nuclear Drug Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Diagnostic Nuclear Drug
Table 44. Key Market Challenges & Risks of Diagnostic Nuclear Drug
Table 45. Key Industry Trends of Diagnostic Nuclear Drug
Table 46. Global Diagnostic Nuclear Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Diagnostic Nuclear Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Diagnostic Nuclear Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Diagnostic Nuclear Drug Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Diagnostic Nuclear Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Diagnostic Nuclear Drug Market Size Market Share Forecast by Application (2023-2028)
Table 52. Bracco Imaging Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 53. Bracco Imaging Diagnostic Nuclear Drug Product Offered
Table 54. Bracco Imaging Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Bracco Imaging Main Business
Table 56. Bracco Imaging Latest Developments
Table 57. Bayer Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 58. Bayer Diagnostic Nuclear Drug Product Offered
Table 59. Bayer Main Business
Table 60. Bayer Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Bayer Latest Developments
Table 62. Curium Pharmaceuticals Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 63. Curium Pharmaceuticals Diagnostic Nuclear Drug Product Offered
Table 64. Curium Pharmaceuticals Main Business
Table 65. Curium Pharmaceuticals Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Curium Pharmaceuticals Latest Developments
Table 67. Nordion Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 68. Nordion Diagnostic Nuclear Drug Product Offered
Table 69. Nordion Main Business
Table 70. Nordion Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Nordion Latest Developments
Table 72. Triad Isotopes Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 73. Triad Isotopes Diagnostic Nuclear Drug Product Offered
Table 74. Triad Isotopes Main Business
Table 75. Triad Isotopes Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Triad Isotopes Latest Developments
Table 77. Lantheus Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 78. Lantheus Diagnostic Nuclear Drug Product Offered
Table 79. Lantheus Main Business
Table 80. Lantheus Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Lantheus Latest Developments
Table 82. GE Healthcare Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 83. GE Healthcare Diagnostic Nuclear Drug Product Offered
Table 84. GE Healthcare Main Business
Table 85. GE Healthcare Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. GE Healthcare Latest Developments
Table 87. China Isotope & Radiation Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 88. China Isotope & Radiation Diagnostic Nuclear Drug Product Offered
Table 89. China Isotope & Radiation Main Business
Table 90. China Isotope & Radiation Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. China Isotope & Radiation Latest Developments
Table 92. Jubilant Pharma Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 93. Jubilant Pharma Diagnostic Nuclear Drug Product Offered
Table 94. Jubilant Pharma Main Business
Table 95. Jubilant Pharma Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Jubilant Pharma Latest Developments
Table 97. Eli Lilly Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 98. Eli Lilly Diagnostic Nuclear Drug Product Offered
Table 99. Eli Lilly Main Business
Table 100. Eli Lilly Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Eli Lilly Latest Developments
Table 102. Novartis Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 103. Novartis Diagnostic Nuclear Drug Product Offered
Table 104. Novartis Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Novartis Main Business
Table 106. Novartis Latest Developments
Table 107. SIEMENS Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 108. SIEMENS Diagnostic Nuclear Drug Product Offered
Table 109. SIEMENS Main Business
Table 110. SIEMENS Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. SIEMENS Latest Developments
Table 112. Dongcheng Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 113. Dongcheng Diagnostic Nuclear Drug Product Offered
Table 114. Dongcheng Main Business
Table 115. Dongcheng Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Dongcheng Latest Developments
Table 117. Navidea Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 118. Navidea Diagnostic Nuclear Drug Product Offered
Table 119. Navidea Main Business
Table 120. Navidea Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Navidea Latest Developments
List of Figures
Figure 1. Diagnostic Nuclear Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Diagnostic Nuclear Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Diagnostic Nuclear Drug Market Size Market Share by Type in 2021
Figure 7. Diagnostic Nuclear Drug in Oncology
Figure 8. Global Diagnostic Nuclear Drug Market: Oncology (2017-2022) & ($ Millions)
Figure 9. Diagnostic Nuclear Drug in Cardiology
Figure 10. Global Diagnostic Nuclear Drug Market: Cardiology (2017-2022) & ($ Millions)
Figure 11. Diagnostic Nuclear Drug in Other
Figure 12. Global Diagnostic Nuclear Drug Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Diagnostic Nuclear Drug Market Size Market Share by Application in 2021
Figure 14. Global Diagnostic Nuclear Drug Revenue Market Share by Player in 2021
Figure 15. Global Diagnostic Nuclear Drug Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Diagnostic Nuclear Drug Market Size 2017-2022 ($ Millions)
Figure 17. APAC Diagnostic Nuclear Drug Market Size 2017-2022 ($ Millions)
Figure 18. Europe Diagnostic Nuclear Drug Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Diagnostic Nuclear Drug Market Size 2017-2022 ($ Millions)
Figure 20. Americas Diagnostic Nuclear Drug Value Market Share by Country in 2021
Figure 21. Americas Diagnostic Nuclear Drug Consumption Market Share by Type in 2021
Figure 22. Americas Diagnostic Nuclear Drug Market Size Market Share by Application in 2021
Figure 23. United States Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Diagnostic Nuclear Drug Market Size Market Share by Region in 2021
Figure 28. APAC Diagnostic Nuclear Drug Market Size Market Share by Application in 2021
Figure 29. China Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Diagnostic Nuclear Drug Market Size Market Share by Country in 2021
Figure 36. Europe Diagnostic Nuclear Drug Market Size Market Share by Type in 2021
Figure 37. Europe Diagnostic Nuclear Drug Market Size Market Share by Application in 2021
Figure 38. Germany Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Application in 2021
Figure 46. Egypt Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Diagnostic Nuclear Drug Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 52. APAC Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 53. Europe Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 55. United States Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 56. Canada Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 59. China Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 60. Japan Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 61. Korea Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 63. India Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 64. Australia Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 65. Germany Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 66. France Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 67. UK Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 68. Italy Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 69. Russia Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 70. Spain Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 73. Israel Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Diagnostic Nuclear Drug Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
